Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) FCF Margin (2017 - 2025)

Historic FCF Margin for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to 2.54%.

  • Selectis Health's FCF Margin rose 147900.0% to 2.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.99%, marking a year-over-year increase of 95600.0%. This contributed to the annual value of 4.71% for FY2024, which is 60900.0% down from last year.
  • According to the latest figures from Q3 2025, Selectis Health's FCF Margin is 2.54%, which was up 147900.0% from 2.31% recorded in Q2 2025.
  • In the past 5 years, Selectis Health's FCF Margin registered a high of 26.23% during Q3 2023, and its lowest value of 20.17% during Q4 2023.
  • For the 5-year period, Selectis Health's FCF Margin averaged around 1.66%, with its median value being 2.31% (2025).
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 365800bps in 2023, then crashed by -384800bps in 2024.
  • Over the past 5 years, Selectis Health's FCF Margin (Quarter) stood at 12.83% in 2021, then plummeted by -67bps to 4.2% in 2022, then crashed by -580bps to 20.17% in 2023, then skyrocketed by 79bps to 4.17% in 2024, then surged by 161bps to 2.54% in 2025.
  • Its last three reported values are 2.54% in Q3 2025, 2.31% for Q2 2025, and 7.78% during Q1 2025.